Elsevier

The Lancet

Volume 303, Issue 7864, 18 May 1974, Pages 956-958
The Lancet

HL-A 27 AND ARTHROPATHIES ASSOCIATED WITH ULCERATIVE COLITIS AND PSORIASIS

https://doi.org/10.1016/S0140-6736(74)91262-8Get rights and content

Abstract

The histocompatibility antigen HL-A 27 (W27) was found in only 22 out of 300 controls, but in 13 out of 18 patients who had ankylosing spondylitis associated with ulcerative colitis. In patients with psoriasis, HL-A 27 was present in 10 out of 41 with peripheral arthropathy, 4 out of 9 with sacroiliitis, and 9 out of 10 with spondylitis.

References (31)

  • D.A. Brewerton et al.

    Lancet

    (1973)
  • D.A. Brewerton et al.

    Lancet

    (1973)
  • D.A. Brewerton et al.

    Lancet

    (1973)
  • D.A. Brewerton et al.

    Lancet

    (1974)
  • K. Aho et al.

    Lancet

    (1973)
  • T.P. Almy et al.

    Gastroenterology

    (1966)
  • J.B. Kirsner

    Clin. Gastroent.

    (1973)
  • M.F.P. Caffrey et al.

    Nature

    (1973)
  • L. Schlosstein et al.

    New Engl. J. Med.

    (1973)
  • D.E. Caughey et al.

    Curr. med. Res. Opin.

    (1974)
  • Population Studies of the Rheumatic Diseases

    (1968)
  • J.M.H. Moll et al.

    Ann. rheum. Dis.

    (1973)
  • P.I. Terasaki et al.

    Nature

    (1964)
  • V. Wright et al.

    Br. med. J.

    (1965)
  • W.M. Court-Brown et al.

    Spec. Rep. Ser. med. Res. Coun.

    (1957)
  • Cited by (112)

    • Axial psoriatic arthritis: An update for dermatologists

      2021, Journal of the American Academy of Dermatology
      Citation Excerpt :

      Uveitis has been identified as a risk factor for PsA, but its role as a risk factor for axial involvement remains unclear.39 A notable risk factor for axial PsA is the presence of HLA-B27.36,40 HLA-B27 is a known key genetic marker of ankylosing spondylitis (AS), is present in more than 80% of patients with AS, and is the only known genetic marker common to AS and axial PsA.41

    • Implications of the diversity of class I HLA associations in psoriatic arthritis

      2016, Clinical Immunology
      Citation Excerpt :

      The spondylitis group of diseases provides an intriguing counterpoise to the predominant class II MHC associated autoimmune disease that they do not reflect the biologic function of the CD4 T cell. The pioneering identification that certain HLA-B*27 alleles were strongly associated with ankylosing spondylitis susceptibility was the basis of this distinction, although how these alleles accomplish this is still not clearly understood [6,7]. The fact that psoriatic arthritis and reactive arthritis/Reiter's syndrome could appear in the setting of the severe immunodeficiency of AIDS with nearly complete depletion of CD4 T cells was a tragic experiment of nature that clearly etched the conclusion that the pathogenesis of the spondylitis group of diseases was completely different from autoimmune diseases such as RA or SLE, and presumably depended on the unregulated persisting CD8 T cell clones that were highly expanded in the ultimately unsuccessful effort HIV and other secondary pathogens [8,9]. This led to the paradigm that the genesis of the spondylitis group of diseases is the recognition by a CD8 T cell of a self-peptide presented by a class I MHC molecule, consistent with the lack of association of an autoantibody response with the diseases of this group [8,9]. This enkindled interest in the spondylitis group of diseases and, in turn, led to a collaboration of investigators at Columbia led by Robert Winchester with Oliver FitzGerald and his colleagues in the Dublin group to use sequence-based HLA typing to study the genotype of a meticulously phenotyped cohort of Irish psoriatic arthritis patients [10].

    • Arthritides

      2013, Clinical Imaging: With Skeletal, Chest, & Abdominal Pattern Differentials: Third Edition
    • Seronegative spondyloarthritis

      2010, Best Practice and Research: Clinical Rheumatology
      Citation Excerpt :

      This pattern of increased mortality is similar to that seen with other inflammatory joint diseases [90–92], raising issues of the role of chronic inflammation in particular as regards cardiovascular mortality across the spectrum. PsA, like the other SpAs, is associated with HLA-B27 [93], predominantly in those individuals with axial symptoms of sacroiliitis or spondylitis (60–70% are HLA-B27 positive) [94–96]. The association is much weaker in predominantly peripheral PsA (24%) [94–96], and no increase in the frequency of HLA-B27 is seen in psoriasis alone (with the exception of pustular psoriasis) [97].

    View all citing articles on Scopus
    View full text